For instance, glypican-3 (GPC3) enhances Wnt/β-catenin signaling by concentrating Wnt ligands near FZD receptors, a mechanism frequently observed in hepatocellular carcinoma (Kolluri and Ho, 2019; Li N. et al., 2019). The gene discussed is GPC3; the disease is hepatocellular carcinoma.